id	sid	tid	token	lemma	pos
gra-1894	1	1	review	review	NOUN
gra-1894	1	2	of	of	ADP
gra-1894	1	3	literature	literature	NOUN
gra-1894	1	4	the	the	DET
gra-1894	1	5	increased	increase	VERB
gra-1894	1	6	cardiovascular	cardiovascular	ADJ
gra-1894	1	7	risk	risk	NOUN
gra-1894	1	8	associated	associate	VERB
gra-1894	1	9	with	with	ADP
gra-1894	1	10	esrd	esrd	PROPN
gra-1894	1	11	has	have	AUX
gra-1894	1	12	been	be	AUX
gra-1894	1	13	well	well	ADV
gra-1894	1	14	established	establish	VERB
gra-1894	1	15	,	,	PUNCT
gra-1894	1	16	and	and	CCONJ
gra-1894	1	17	estimated	estimate	VERB
gra-1894	1	18	cardiovascular	cardiovascular	ADJ
gra-1894	1	19	mortality	mortality	NOUN
gra-1894	1	20	rates	rate	NOUN
gra-1894	1	21	are	be	AUX
gra-1894	1	22	ten	ten	NUM
gra-1894	1	23	to	to	ADP
gra-1894	1	24	one	one	NUM
gra-1894	1	25	hundred	hundred	NUM
gra-1894	1	26	fold	fold	ADV
gra-1894	1	27	higher	higher	ADV
gra-1894	1	28	among	among	ADP
gra-1894	1	29	dialysis	dialysis	NOUN
gra-1894	1	30	patients	patient	NOUN
gra-1894	1	31	than	than	ADP
gra-1894	1	32	ageand	ageand	NOUN
gra-1894	1	33	sex	sex	NOUN
gra-1894	1	34	-	-	PUNCT
gra-1894	1	35	matched	match	VERB
gra-1894	1	36	individuals	individual	NOUN
gra-1894	1	37	in	in	ADP
gra-1894	1	38	the	the	DET
gra-1894	1	39	general	general	ADJ
gra-1894	1	40	population	population	NOUN
gra-1894	1	41	.	.	PUNCT
gra-1894	2	1	the	the	DET
gra-1894	2	2	cardiovascular	cardiovascular	ADJ
gra-1894	2	3	risk	risk	NOUN
gra-1894	2	4	associated	associate	VERB
gra-1894	2	5	with	with	ADP
gra-1894	2	6	renal	renal	ADJ
gra-1894	2	7	impairment	impairment	ADJ
gra-1894	2	8	increases	increase	NOUN
gra-1894	2	9	earlier	early	ADV
gra-1894	2	10	in	in	ADP
gra-1894	2	11	the	the	DET
gra-1894	2	12	course	course	NOUN
gra-1894	2	13	of	of	ADP
gra-1894	2	14	renal	renal	ADJ
gra-1894	2	15	disease	disease	NOUN
gra-1894	2	16	progression	progression	NOUN
gra-1894	2	17	than	than	SCONJ
gra-1894	2	18	was	be	AUX
gra-1894	2	19	initially	initially	ADV
gra-1894	2	20	hypothesized	hypothesize	VERB
gra-1894	2	21	.	.	PUNCT
gra-1894	3	1	more	more	ADV
gra-1894	3	2	specically	specically	ADV
gra-1894	3	3	,	,	PUNCT
gra-1894	3	4	there	there	PRON
gra-1894	3	5	are	be	VERB
gra-1894	3	6	evidences	evidence	NOUN
gra-1894	3	7	that	that	SCONJ
gra-1894	3	8	even	even	ADV
gra-1894	3	9	mild	mild	ADJ
gra-1894	3	10	to	to	ADP
gra-1894	3	11	moderate	moderate	ADJ
gra-1894	3	12	degrees	degree	NOUN
gra-1894	3	13	of	of	ADP
gra-1894	3	14	renal	renal	ADJ
gra-1894	3	15	impairment	impairment	NOUN
gra-1894	3	16	are	be	AUX
gra-1894	3	17	associated	associate	VERB
gra-1894	3	18	with	with	ADP
gra-1894	3	19	increased	increase	VERB
gra-1894	3	20	cardiovascular	cardiovascular	ADJ
gra-1894	3	21	risk	risk	NOUN
gra-1894	3	22	.	.	PUNCT
gra-1894	4	1	many	many	ADJ
gra-1894	4	2	traditional	traditional	ADJ
gra-1894	4	3	cardiovascular	cardiovascular	ADJ
gra-1894	4	4	risk	risk	NOUN
gra-1894	4	5	factors	factor	NOUN
gra-1894	4	6	,	,	PUNCT
gra-1894	4	7	documented	document	VERB
gra-1894	4	8	in	in	ADP
gra-1894	4	9	the	the	DET
gra-1894	4	10	general	general	ADJ
gra-1894	4	11	population	population	NOUN
gra-1894	4	12	,	,	PUNCT
gra-1894	4	13	contribute	contribute	VERB
gra-1894	4	14	to	to	ADP
gra-1894	4	15	cardiovascular	cardiovascular	ADJ
gra-1894	4	16	risk	risk	NOUN
gra-1894	4	17	in	in	ADP
gra-1894	4	18	ckd	ckd	NOUN
gra-1894	4	19	patients	patient	NOUN
gra-1894	4	20	.	.	PUNCT
gra-1894	5	1	in	in	ADP
gra-1894	5	2	fact	fact	NOUN
gra-1894	5	3	,	,	PUNCT
gra-1894	5	4	many	many	ADJ
gra-1894	5	5	framingham	framingham	PROPN
gra-1894	5	6	risk	risk	NOUN
gra-1894	5	7	factors	factor	NOUN
gra-1894	5	8	are	be	AUX
gra-1894	5	9	more	more	ADV
gra-1894	5	10	prevalent	prevalent	ADJ
gra-1894	5	11	among	among	ADP
gra-1894	5	12	(	(	PUNCT
gra-1894	5	13	3)individuals	3)individual	NOUN
gra-1894	5	14	with	with	ADP
gra-1894	5	15	ckd	ckd	PROPN
gra-1894	5	16	than	than	ADP
gra-1894	5	17	those	those	PRON
gra-1894	5	18	with	with	ADP
gra-1894	5	19	normal	normal	ADJ
gra-1894	5	20	kidney	kidney	NOUN
gra-1894	5	21	function	function	NOUN
gra-1894	5	22	.	.	PUNCT
gra-1894	6	1	hypertension	hypertension	NOUN
gra-1894	6	2	is	be	AUX
gra-1894	6	3	cardiovascular	cardiovascular	ADJ
gra-1894	6	4	risk	risk	NOUN
gra-1894	6	5	factor	factor	NOUN
gra-1894	6	6	which	which	PRON
gra-1894	6	7	contributes	contribute	VERB
gra-1894	6	8	to	to	ADP
gra-1894	6	9	the	the	DET
gra-1894	6	10	cardiovascular	cardiovascular	ADJ
gra-1894	6	11	risk	risk	NOUN
gra-1894	6	12	associated	associate	VERB
gra-1894	6	13	with	with	ADP
gra-1894	6	14	ckd	ckd	PROPN
gra-1894	6	15	.	.	PROPN
gra-1894	6	16	szcech	szcech	PROPN
gra-1894	6	17	and	and	CCONJ
gra-1894	6	18	colleagues	colleague	NOUN
gra-1894	6	19	demonstrated	demonstrate	VERB
gra-1894	6	20	that	that	SCONJ
gra-1894	6	21	patients	patient	NOUN
gra-1894	6	22	with	with	ADP
gra-1894	6	23	hypertension	hypertension	NOUN
gra-1894	6	24	are	be	AUX
gra-1894	6	25	susceptible	susceptible	ADJ
gra-1894	6	26	to	to	ADP
gra-1894	6	27	increased	increase	VERB
gra-1894	6	28	risk	risk	NOUN
gra-1894	6	29	for	for	ADP
gra-1894	6	30	new	new	ADJ
gra-1894	6	31	or	or	CCONJ
gra-1894	6	32	recurrent	recurrent	ADJ
gra-1894	6	33	(	(	PUNCT
gra-1894	6	34	7	7	X
gra-1894	6	35	)	)	PUNCT
gra-1894	6	36	cardiovascular	cardiovascular	ADJ
gra-1894	6	37	events	event	NOUN
gra-1894	6	38	in	in	ADP
gra-1894	6	39	individuals	individual	NOUN
gra-1894	6	40	with	with	ADP
gra-1894	6	41	stage	stage	NOUN
gra-1894	6	42	2–3	2–3	NUM
gra-1894	6	43	ckd	ckd	PROPN
gra-1894	6	44	.	.	PUNCT
gra-1894	7	1	systolic	systolic	ADJ
gra-1894	7	2	blood	blood	NOUN
gra-1894	7	3	pressure	pressure	NOUN
gra-1894	7	4	is	be	AUX
gra-1894	7	5	more	more	ADV
gra-1894	7	6	strongly	strongly	ADV
gra-1894	7	7	associated	associate	VERB
gra-1894	7	8	with	with	ADP
gra-1894	7	9	cardiovascular	cardiovascular	ADJ
gra-1894	7	10	death	death	NOUN
gra-1894	7	11	in	in	ADP
gra-1894	7	12	esrd	esrd	PROPN
gra-1894	7	13	patients	patient	NOUN
gra-1894	7	14	on	on	ADP
gra-1894	7	15	dialysis	dialysis	NOUN
gra-1894	7	16	than	than	ADP
gra-1894	7	17	either	either	CCONJ
gra-1894	7	18	pulse	pulse	NOUN
gra-1894	7	19	or	or	CCONJ
gra-1894	7	20	diastolic	diastolic	ADJ
gra-1894	7	21	pressure	pressure	NOUN
gra-1894	7	22	.	.	PUNCT
gra-1894	8	1	however	however	ADV
gra-1894	8	2	,	,	PUNCT
gra-1894	8	3	a	a	DET
gra-1894	8	4	u	u	ADJ
gra-1894	8	5	-	-	ADJ
gra-1894	8	6	shaped	shape	VERB
gra-1894	8	7	relationship	relationship	NOUN
gra-1894	8	8	found	find	VERB
gra-1894	8	9	between	between	ADP
gra-1894	8	10	systolic	systolic	ADJ
gra-1894	8	11	blood	blood	NOUN
gra-1894	8	12	pressure	pressure	NOUN
gra-1894	8	13	and	and	CCONJ
gra-1894	8	14	mortality	mortality	NOUN
gra-1894	8	15	in	in	ADP
gra-1894	8	16	which	which	PRON
gra-1894	8	17	high	high	ADJ
gra-1894	8	18	or	or	CCONJ
gra-1894	8	19	low	low	ADJ
gra-1894	8	20	systolic	systolic	ADJ
gra-1894	8	21	blood	blood	NOUN
gra-1894	8	22	pressures	pressure	NOUN
gra-1894	8	23	appear	appear	VERB
gra-1894	8	24	to	to	PART
gra-1894	8	25	be	be	AUX
gra-1894	8	26	associated	associate	VERB
gra-1894	8	27	with	with	ADP
gra-1894	8	28	increased	increase	VERB
gra-1894	8	29	mortality	mortality	NOUN
gra-1894	8	30	rates	rate	NOUN
gra-1894	8	31	in	in	ADP
gra-1894	8	32	stage	stage	NOUN
gra-1894	8	33	5	5	NUM
gra-1894	8	34	ckd	ckd	NOUN
gra-1894	8	35	patients	patient	NOUN
gra-1894	8	36	.	.	PUNCT
gra-1894	9	1	the	the	DET
gra-1894	9	2	presence	presence	NOUN
gra-1894	9	3	of	of	ADP
gra-1894	9	4	left	left	ADJ
gra-1894	9	5	ventricular	ventricular	ADJ
gra-1894	9	6	hypertrophy	hypertrophy	NOUN
gra-1894	9	7	(	(	PUNCT
gra-1894	9	8	lvh	lvh	PROPN
gra-1894	9	9	)	)	PUNCT
gra-1894	9	10	is	be	AUX
gra-1894	9	11	also	also	ADV
gra-1894	9	12	a	a	DET
gra-1894	9	13	cardiovascular	cardiovascular	ADJ
gra-1894	9	14	risk	risk	NOUN
gra-1894	9	15	determinant	determinant	ADJ
gra-1894	9	16	in	in	ADP
gra-1894	9	17	ckd	ckd	PROPN
gra-1894	9	18	patients	patient	NOUN
gra-1894	9	19	.	.	PUNCT
gra-1894	10	1	anemia	anemia	NOUN
gra-1894	10	2	and	and	CCONJ
gra-1894	10	3	hypertension	hypertension	NOUN
gra-1894	10	4	are	be	AUX
gra-1894	10	5	two	two	NUM
gra-1894	10	6	ckd	ckd	PROPN
gra-1894	10	7	associated	associate	VERB
gra-1894	10	8	complications	complication	NOUN
gra-1894	10	9	hypothesized	hypothesize	VERB
gra-1894	10	10	to	to	PART
gra-1894	10	11	play	play	VERB
gra-1894	10	12	a	a	DET
gra-1894	10	13	signicant	signicant	ADJ
gra-1894	10	14	role	role	NOUN
gra-1894	10	15	in	in	ADP
gra-1894	10	16	the	the	DET
gra-1894	10	17	development	development	NOUN
gra-1894	10	18	of	of	ADP
gra-1894	10	19	(	(	PUNCT
gra-1894	10	20	8)lvh	8)lvh	NUM
gra-1894	10	21	.	.	PUNCT
gra-1894	11	1	in	in	ADP
gra-1894	11	2	a	a	DET
gra-1894	11	3	cohort	cohort	NOUN
gra-1894	11	4	of	of	ADP
gra-1894	11	5	2,423	2,423	NUM
gra-1894	11	6	patients	patient	NOUN
gra-1894	11	7	with	with	ADP
gra-1894	11	8	stage	stage	NOUN
gra-1894	11	9	3–4	3–4	NUM
gra-1894	11	10	ckd	ckd	NOUN
gra-1894	11	11	,	,	PUNCT
gra-1894	11	12	investigators	investigator	NOUN
gra-1894	11	13	noted	note	VERB
gra-1894	11	14	an	an	DET
gra-1894	11	15	independent	independent	ADJ
gra-1894	11	16	risk	risk	NOUN
gra-1894	11	17	of	of	ADP
gra-1894	11	18	lvh	lvh	PROPN
gra-1894	11	19	for	for	ADP
gra-1894	11	20	the	the	DET
gra-1894	11	21	composite	composite	ADJ
gra-1894	11	22	endpoint	endpoint	NOUN
gra-1894	11	23	of	of	ADP
gra-1894	11	24	myocardial	myocardial	ADJ
gra-1894	11	25	infarction	infarction	NOUN
gra-1894	11	26	and	and	CCONJ
gra-1894	11	27	fatal	fatal	ADJ
gra-1894	11	28	coronary	coronary	ADJ
gra-1894	11	29	heart	heart	NOUN
gra-1894	11	30	disease	disease	NOUN
gra-1894	11	31	.	.	PUNCT
gra-1894	12	1	patients	patient	NOUN
gra-1894	12	2	were	be	AUX
gra-1894	12	3	followed	follow	VERB
gra-1894	12	4	over	over	ADP
gra-1894	12	5	a	a	DET
gra-1894	12	6	period	period	NOUN
gra-1894	12	7	of	of	ADP
gra-1894	12	8	102	102	NUM
gra-1894	12	9	months	month	NOUN
gra-1894	12	10	.	.	PUNCT
gra-1894	13	1	in	in	ADP
gra-1894	13	2	adjusted	adjusted	ADJ
gra-1894	13	3	analysis	analysis	NOUN
gra-1894	13	4	,	,	PUNCT
gra-1894	13	5	lvh	lvh	PROPN
gra-1894	13	6	was	be	AUX
gra-1894	13	7	associated	associate	VERB
gra-1894	13	8	with	with	ADP
gra-1894	13	9	increased	increase	VERB
gra-1894	13	10	risk	risk	NOUN
gra-1894	13	11	for	for	ADP
gra-1894	13	12	composite	composite	ADJ
gra-1894	13	13	and	and	CCONJ
gra-1894	13	14	cardiac	cardiac	ADJ
gra-1894	13	15	outcomes	outcome	NOUN
gra-1894	13	16	hazard	hazard	NOUN
gra-1894	13	17	ratio	ratio	NOUN
gra-1894	13	18	(	(	PUNCT
gra-1894	13	19	hr	hr	NOUN
gra-1894	13	20	1.67	1.67	NUM
gra-1894	13	21	;	;	PUNCT
gra-1894	13	22	95	95	NUM
gra-1894	13	23	%	%	NOUN
gra-1894	13	24	ci	ci	NOUN
gra-1894	13	25	1.34	1.34	NUM
gra-1894	13	26	to	to	PART
gra-1894	13	27	2	2	NUM
gra-1894	13	28	.	.	NOUN
gra-1894	13	29	07).addictions	07).addictions	NUM
gra-1894	13	30	like	like	ADP
gra-1894	13	31	tobacco	tobacco	NOUN
gra-1894	13	32	use	use	NOUN
gra-1894	13	33	is	be	AUX
gra-1894	13	34	also	also	ADV
gra-1894	13	35	associated	associate	VERB
gra-1894	13	36	with	with	ADP
gra-1894	13	37	increased	increase	VERB
gra-1894	13	38	mortality	mortality	NOUN
gra-1894	13	39	and	and	CCONJ
gra-1894	13	40	incidence	incidence	NOUN
gra-1894	13	41	of	of	ADP
gra-1894	13	42	(	(	PUNCT
gra-1894	13	43	24)heart	24)heart	NUM
gra-1894	13	44	failure	failure	NOUN
gra-1894	13	45	among	among	ADP
gra-1894	13	46	patients	patient	NOUN
gra-1894	13	47	with	with	ADP
gra-1894	13	48	stage	stage	NOUN
gra-1894	13	49	5	5	NUM
gra-1894	13	50	ckd	ckd	NOUN
gra-1894	13	51	.	.	PUNCT
gra-1894	13	52	results	result	NOUN
gra-1894	13	53	in	in	ADP
gra-1894	13	54	our	our	PRON
gra-1894	13	55	study	study	NOUN
gra-1894	13	56	of	of	ADP
gra-1894	13	57	esrd	esrd	PROPN
gra-1894	13	58	patients	patient	NOUN
gra-1894	13	59	out	out	ADP
gra-1894	13	60	of	of	ADP
gra-1894	13	61	140	140	NUM
gra-1894	13	62	patients	patient	NOUN
gra-1894	13	63	68	68	NUM
gra-1894	13	64	(	(	PUNCT
gra-1894	13	65	48.6	48.6	NUM
gra-1894	13	66	%	%	NOUN
gra-1894	13	67	)	)	PUNCT
gra-1894	13	68	were	be	AUX
gra-1894	13	69	male	male	ADJ
gra-1894	13	70	and	and	CCONJ
gra-1894	13	71	72	72	NUM
gra-1894	13	72	(	(	PUNCT
gra-1894	13	73	51.4	51.4	NUM
gra-1894	13	74	%	%	NOUN
gra-1894	13	75	)	)	PUNCT
gra-1894	13	76	were	be	AUX
gra-1894	13	77	female	female	ADJ
gra-1894	13	78	.	.	PUNCT
gra-1894	14	1	in	in	ADP
gra-1894	14	2	our	our	PRON
gra-1894	14	3	study	study	NOUN
gra-1894	14	4	maximum	maximum	ADJ
gra-1894	14	5	patient	patient	NOUN
gra-1894	14	6	were	be	AUX
gra-1894	14	7	between	between	ADP
gra-1894	14	8	41	41	NUM
gra-1894	14	9	to	to	PART
gra-1894	14	10	50	50	NUM
gra-1894	14	11	years	year	NOUN
gra-1894	14	12	of	of	ADP
gra-1894	14	13	age	age	NOUN
gra-1894	14	14	52	52	NUM
gra-1894	14	15	(	(	PUNCT
gra-1894	14	16	37	37	NUM
gra-1894	14	17	%	%	NOUN
gra-1894	14	18	)	)	PUNCT
gra-1894	14	19	out	out	ADP
gra-1894	14	20	of	of	ADP
gra-1894	14	21	140	140	NUM
gra-1894	14	22	.	.	PUNCT
gra-1894	15	1	table	table	NOUN
gra-1894	15	2	no.1	no.1	VERB
gra-1894	15	3	distribution	distribution	NOUN
gra-1894	15	4	patients	patient	NOUN
gra-1894	15	5	according	accord	VERB
gra-1894	15	6	to	to	ADP
gra-1894	15	7	the	the	DET
gra-1894	15	8	age	age	NOUN
gra-1894	15	9	figure	figure	NOUN
gra-1894	15	10	no.1	no.1	VERB
gra-1894	15	11	distribution	distribution	NOUN
gra-1894	15	12	patients	patient	NOUN
gra-1894	15	13	according	accord	VERB
gra-1894	15	14	to	to	ADP
gra-1894	15	15	the	the	DET
gra-1894	15	16	age	age	NOUN
gra-1894	15	17	in	in	ADP
gra-1894	15	18	our	our	PRON
gra-1894	15	19	study	study	NOUN
gra-1894	15	20	out	out	ADP
gra-1894	15	21	of	of	ADP
gra-1894	15	22	140	140	NUM
gra-1894	15	23	patients	patient	NOUN
gra-1894	15	24	lvh	lvh	PROPN
gra-1894	15	25	was	be	AUX
gra-1894	15	26	present	present	ADJ
gra-1894	15	27	64(45.7	64(45.7	NOUN
gra-1894	15	28	%	%	NOUN
gra-1894	15	29	)	)	PUNCT
gra-1894	16	1	patients	patient	NOUN
gra-1894	16	2	,	,	PUNCT
gra-1894	16	3	2	2	NUM
gra-1894	16	4	decho	decho	NOUN
gra-1894	16	5	was	be	AUX
gra-1894	16	6	normal	normal	ADJ
gra-1894	16	7	in	in	ADP
gra-1894	16	8	60(42.9%),reduced	60(42.9%),reduced	ADJ
gra-1894	16	9	ejection	ejection	NOUN
gra-1894	16	10	fraction	fraction	NOUN
gra-1894	16	11	in	in	ADP
gra-1894	16	12	4(2.9	4(2.9	NUM
gra-1894	16	13	%	%	NOUN
gra-1894	16	14	)	)	PUNCT
gra-1894	16	15	,	,	PUNCT
gra-1894	16	16	valvular	valvular	ADJ
gra-1894	16	17	heart	heart	NOUN
gra-1894	16	18	disease	disease	NOUN
gra-1894	16	19	in	in	ADP
gra-1894	16	20	4(2.9	4(2.9	NUM
gra-1894	16	21	%	%	NOUN
gra-1894	16	22	)	)	PUNCT
gra-1894	16	23	.	.	PUNCT
gra-1894	17	1	table	table	NOUN
gra-1894	17	2	2	2	NUM
gra-1894	17	3	:	:	PUNCT
gra-1894	17	4	findings	finding	NOUN
gra-1894	17	5	on	on	ADP
gra-1894	17	6	2d	2d	NUM
gra-1894	17	7	echo	echo	NOUN
gra-1894	17	8	figure	figure	NOUN
gra-1894	17	9	no.2	no.2	PROPN
gra-1894	17	10	:	:	PUNCT
gra-1894	17	11	percentage	percentage	NOUN
gra-1894	17	12	of	of	ADP
gra-1894	17	13	2d	2d	NUM
gra-1894	17	14	echo	echo	VERB
gra-1894	17	15	ndings	nding	NOUN
gra-1894	17	16	in	in	ADP
gra-1894	17	17	esrd	esrd	PROPN
gra-1894	17	18	echocardiographic	echocardiographic	ADJ
gra-1894	17	19	findings	finding	NOUN
gra-1894	17	20	in	in	ADP
gra-1894	17	21	patients	patient	NOUN
gra-1894	17	22	with	with	ADP
gra-1894	17	23	end	end	NOUN
gra-1894	17	24	stage	stage	NOUN
gra-1894	17	25	renal	renal	ADJ
gra-1894	17	26	disease	disease	NOUN
gra-1894	17	27	undergoing	undergo	VERB
gra-1894	17	28	hemodialysis	hemodialysis	NOUN
gra-1894	17	29	original	original	ADJ
gra-1894	17	30	research	research	NOUN
gra-1894	17	31	paper	paper	NOUN
gra-1894	17	32	shilpa	shilpa	PROPN
gra-1894	17	33	gadade	gadade	PROPN
gra-1894	17	34	junior	junior	ADJ
gra-1894	17	35	resident	resident	NOUN
gra-1894	17	36	,	,	PUNCT
gra-1894	17	37	department	department	NOUN
gra-1894	17	38	of	of	ADP
gra-1894	17	39	general	general	ADJ
gra-1894	17	40	medicine	medicine	NOUN
gra-1894	17	41	,	,	PUNCT
gra-1894	17	42	d.y	d.y	PROPN
gra-1894	17	43	.	.	PROPN
gra-1894	17	44	patil	patil	PROPN
gra-1894	17	45	medical	medical	PROPN
gra-1894	17	46	college	college	PROPN
gra-1894	17	47	and	and	CCONJ
gra-1894	17	48	hospital	hospital	NOUN
gra-1894	17	49	,	,	PUNCT
gra-1894	17	50	navi	navi	PROPN
gra-1894	17	51	mumbai	mumbai	PROPN
gra-1894	17	52	general	general	ADJ
gra-1894	17	53	medicine	medicine	NOUN
gra-1894	17	54	introduction	introduction	NOUN
gra-1894	17	55	:	:	PUNCT
gra-1894	18	1	chronic	chronic	ADJ
gra-1894	18	2	kidney	kidney	NOUN
gra-1894	18	3	disease	disease	NOUN
gra-1894	18	4	(	(	PUNCT
gra-1894	18	5	ckd	ckd	NOUN
gra-1894	18	6	)	)	PUNCT
gra-1894	18	7	has	have	AUX
gra-1894	18	8	emerged	emerge	VERB
gra-1894	18	9	as	as	ADP
gra-1894	18	10	a	a	DET
gra-1894	18	11	major	major	ADJ
gra-1894	18	12	public	public	ADJ
gra-1894	18	13	health	health	NOUN
gra-1894	18	14	problem	problem	NOUN
gra-1894	18	15	.most	.most	PUNCT
gra-1894	19	1	(	(	PUNCT
gra-1894	19	2	1)common	1)common	NUM
gra-1894	19	3	causes	cause	NOUN
gra-1894	19	4	of	of	ADP
gra-1894	19	5	ckd	ckd	PROPN
gra-1894	19	6	are	be	AUX
gra-1894	19	7	diabetes	diabetes	NOUN
gra-1894	19	8	and	and	CCONJ
gra-1894	19	9	hypertension	hypertension	NOUN
gra-1894	19	10	.	.	PUNCT
gra-1894	20	1	hypertension	hypertension	NOUN
gra-1894	20	2	is	be	AUX
gra-1894	20	3	cause	cause	NOUN
gra-1894	20	4	as	as	ADV
gra-1894	20	5	well	well	ADV
gra-1894	20	6	as	as	ADP
gra-1894	20	7	effect	effect	NOUN
gra-1894	20	8	of	of	ADP
gra-1894	20	9	ckd.ckd	ckd.ckd	PROPN
gra-1894	20	10	is	be	AUX
gra-1894	20	11	risk	risk	NOUN
gra-1894	20	12	for	for	ADP
gra-1894	20	13	adverse	adverse	ADJ
gra-1894	20	14	cardiovascular	cardiovascular	ADJ
gra-1894	20	15	events	event	NOUN
gra-1894	20	16	.criteria	.criteria	PRON
gra-1894	20	17	for	for	ADP
gra-1894	20	18	ckd	ckd	PROPN
gra-1894	20	19	(	(	PUNCT
gra-1894	20	20	either	either	CCONJ
gra-1894	20	21	of	of	ADP
gra-1894	20	22	the	the	DET
gra-1894	20	23	following	follow	VERB
gra-1894	20	24	present	present	NOUN
gra-1894	20	25	for	for	ADP
gra-1894	20	26	>	>	X
gra-1894	20	27	3	3	NUM
gra-1894	20	28	months	month	NOUN
gra-1894	20	29	)	)	PUNCT
gra-1894	20	30	is	be	AUX
gra-1894	20	31	as	as	SCONJ
gra-1894	20	32	follows	follow	VERB
gra-1894	20	33	:	:	PUNCT
gra-1894	20	34	markers	marker	NOUN
gra-1894	20	35	of	of	ADP
gra-1894	20	36	kidney	kidney	NOUN
gra-1894	20	37	damage	damage	NOUN
gra-1894	20	38	(	(	PUNCT
gra-1894	20	39	one	one	NUM
gra-1894	20	40	or	or	CCONJ
gra-1894	20	41	more	more	ADJ
gra-1894	20	42	)	)	PUNCT
gra-1894	20	43	albuminuria	albuminuria	NOUN
gra-1894	20	44	(	(	PUNCT
gra-1894	20	45	aer	aer	X
gra-1894	20	46	>	>	X
gra-1894	20	47	or	or	CCONJ
gra-1894	20	48	equal	equal	ADJ
gra-1894	20	49	to30	to30	PROPN
gra-1894	20	50	mg/24	mg/24	PROPN
gra-1894	20	51	hours	hour	NOUN
gra-1894	20	52	;	;	PUNCT
gra-1894	20	53	acr	acr	NOUN
gra-1894	20	54	>	>	PUNCT
gra-1894	20	55	or	or	CCONJ
gra-1894	20	56	equal	equal	ADJ
gra-1894	20	57	to30	to30	PROPN
gra-1894	20	58	mg	mg	PROPN
gra-1894	20	59	/	/	SYM
gra-1894	20	60	g	g	NOUN
gra-1894	20	61	>	>	PUNCT
gra-1894	20	62	or	or	CCONJ
gra-1894	20	63	equal	equal	ADJ
gra-1894	20	64	(	(	PUNCT
gra-1894	20	65	2)to	2)to	NOUN
gra-1894	20	66	3	3	NUM
gra-1894	20	67	mg	mg	NUM
gra-1894	20	68	/	/	SYM
gra-1894	20	69	mmol	mmol	NOUN
gra-1894	20	70	]	]	PUNCT
gra-1894	20	71	)	)	PUNCT
gra-1894	20	72	aims	aim	VERB
gra-1894	20	73	and	and	CCONJ
gra-1894	20	74	objectives	objective	NOUN
gra-1894	20	75	:	:	PUNCT
gra-1894	20	76	to	to	PART
gra-1894	20	77	asses	asse	VERB
gra-1894	20	78	echocardiographic	echocardiographic	ADJ
gra-1894	20	79	changes	change	NOUN
gra-1894	20	80	in	in	ADP
gra-1894	20	81	patients	patient	NOUN
gra-1894	20	82	of	of	ADP
gra-1894	20	83	end	end	NOUN
gra-1894	20	84	stage	stage	NOUN
gra-1894	20	85	renal	renal	ADJ
gra-1894	20	86	disease	disease	NOUN
gra-1894	20	87	undergoing	undergo	VERB
gra-1894	20	88	hemo	hemo	PROPN
gra-1894	20	89	dialysis	dialysis	NOUN
gra-1894	20	90	materials	material	NOUN
gra-1894	20	91	and	and	CCONJ
gra-1894	20	92	methods	method	NOUN
gra-1894	20	93	:	:	PUNCT
gra-1894	20	94	this	this	DET
gra-1894	20	95	prospective	prospective	ADJ
gra-1894	20	96	observational	observational	ADJ
gra-1894	20	97	study	study	NOUN
gra-1894	20	98	was	be	AUX
gra-1894	20	99	conducted	conduct	VERB
gra-1894	20	100	in	in	ADP
gra-1894	20	101	department	department	NOUN
gra-1894	20	102	of	of	ADP
gra-1894	20	103	general	general	ADJ
gra-1894	20	104	medicine	medicine	NOUN
gra-1894	20	105	,	,	PUNCT
gra-1894	20	106	d.y	d.y	PROPN
gra-1894	20	107	patil	patil	PROPN
gra-1894	20	108	hospital	hospital	PROPN
gra-1894	20	109	,	,	PUNCT
gra-1894	20	110	nerul	nerul	PROPN
gra-1894	20	111	,	,	PUNCT
gra-1894	20	112	navi	navi	PROPN
gra-1894	20	113	mumbai	mumbai	PROPN
gra-1894	20	114	.	.	PUNCT
gra-1894	21	1	the	the	DET
gra-1894	21	2	study	study	NOUN
gra-1894	21	3	was	be	AUX
gra-1894	21	4	started	start	VERB
gra-1894	21	5	after	after	ADP
gra-1894	21	6	the	the	DET
gra-1894	21	7	approval	approval	NOUN
gra-1894	21	8	of	of	ADP
gra-1894	21	9	institutional	institutional	ADJ
gra-1894	21	10	ethics	ethic	NOUN
gra-1894	21	11	committee	committee	NOUN
gra-1894	21	12	.	.	PUNCT
gra-1894	22	1	a	a	DET
gra-1894	22	2	written	write	VERB
gra-1894	22	3	signed	sign	VERB
gra-1894	22	4	informed	informed	ADJ
gra-1894	22	5	consent	consent	NOUN
gra-1894	22	6	was	be	AUX
gra-1894	22	7	taken	take	VERB
gra-1894	22	8	prior	prior	ADV
gra-1894	22	9	to	to	ADP
gra-1894	22	10	enrolling	enrol	VERB
gra-1894	22	11	the	the	DET
gra-1894	22	12	subjects	subject	NOUN
gra-1894	22	13	in	in	ADP
gra-1894	22	14	the	the	DET
gra-1894	22	15	study	study	NOUN
gra-1894	22	16	.	.	PUNCT
gra-1894	23	1	a	a	DET
gra-1894	23	2	total	total	NOUN
gra-1894	23	3	of	of	ADP
gra-1894	23	4	140	140	NUM
gra-1894	23	5	patients	patient	NOUN
gra-1894	23	6	presenting	present	VERB
gra-1894	23	7	with	with	ADP
gra-1894	23	8	symptoms	symptom	NOUN
gra-1894	23	9	of	of	ADP
gra-1894	23	10	esrd	esrd	PROPN
gra-1894	23	11	on	on	ADP
gra-1894	23	12	hemodialysis	hemodialysis	NOUN
gra-1894	23	13	was	be	AUX
gra-1894	23	14	taken	take	VERB
gra-1894	23	15	.	.	PUNCT
gra-1894	24	1	detailed	detailed	ADJ
gra-1894	24	2	history	history	NOUN
gra-1894	24	3	and	and	CCONJ
gra-1894	24	4	through	through	ADP
gra-1894	24	5	examination	examination	NOUN
gra-1894	24	6	was	be	AUX
gra-1894	24	7	done	do	VERB
gra-1894	24	8	.	.	PUNCT
gra-1894	25	1	abstract	abstract	ADJ
gra-1894	25	2	keywords	keyword	NOUN
gra-1894	25	3	:	:	PUNCT
gra-1894	25	4	esrd	esrd	PROPN
gra-1894	25	5	(	(	PUNCT
gra-1894	25	6	end	end	NOUN
gra-1894	25	7	stage	stage	NOUN
gra-1894	25	8	renal	renal	PROPN
gra-1894	25	9	disese)/echocardiography	disese)/echocardiography	PROPN
gra-1894	25	10	/	/	SYM
gra-1894	25	11	lvh	lvh	PROPN
gra-1894	25	12	(	(	PUNCT
gra-1894	25	13	left	leave	VERB
gra-1894	25	14	ventricular	ventricular	ADJ
gra-1894	25	15	hypertrophy	hypertrophy	NOUN
gra-1894	25	16	volume-9	volume-9	NOUN
gra-1894	25	17	,	,	PUNCT
gra-1894	25	18	issue-2	issue-2	PROPN
gra-1894	25	19	,	,	PUNCT
gra-1894	25	20	february-2020	february-2020	VERB
gra-1894	25	21	•	•	NUM
gra-1894	25	22	print	print	NOUN
gra-1894	25	23	issn	issn	PROPN
gra-1894	25	24	no	no	NOUN
gra-1894	25	25	.	.	PROPN
gra-1894	25	26	2277	2277	NUM
gra-1894	25	27	8160	8160	NUM
gra-1894	25	28	•	•	NOUN
gra-1894	25	29	doi	doi	NOUN
gra-1894	25	30	:	:	PUNCT
gra-1894	25	31	10.36106	10.36106	NUM
gra-1894	25	32	/	/	SYM
gra-1894	25	33	gjra	gjra	ADJ
gra-1894	25	34	smita	smita	PROPN
gra-1894	25	35	patil	patil	PROPN
gra-1894	25	36	*	*	PROPN
gra-1894	25	37	professor	professor	PROPN
gra-1894	25	38	,	,	PUNCT
gra-1894	25	39	department	department	NOUN
gra-1894	25	40	of	of	ADP
gra-1894	25	41	general	general	ADJ
gra-1894	25	42	medicine	medicine	NOUN
gra-1894	25	43	,	,	PUNCT
gra-1894	25	44	d.y	d.y	PROPN
gra-1894	25	45	.	.	PROPN
gra-1894	25	46	patil	patil	PROPN
gra-1894	25	47	medical	medical	PROPN
gra-1894	25	48	college	college	PROPN
gra-1894	25	49	and	and	CCONJ
gra-1894	25	50	hospital	hospital	NOUN
gra-1894	25	51	,	,	PUNCT
gra-1894	25	52	navi	navi	PROPN
gra-1894	25	53	mumbai	mumbai	PROPN
gra-1894	25	54	*	*	PUNCT
gra-1894	25	55	corresponding	correspond	VERB
gra-1894	25	56	author	author	NOUN
gra-1894	25	57	age	age	NOUN
gra-1894	25	58	group	group	NOUN
gra-1894	25	59	(	(	PUNCT
gra-1894	25	60	years	year	NOUN
gra-1894	25	61	)	)	PUNCT
gra-1894	25	62	number	number	NOUN
gra-1894	25	63	of	of	ADP
gra-1894	25	64	patients	patient	NOUN
gra-1894	25	65	percentage	percentage	VERB
gra-1894	25	66	21	21	NUM
gra-1894	25	67	to	to	PART
gra-1894	25	68	30	30	NUM
gra-1894	25	69	20	20	NUM
gra-1894	25	70	14.3	14.3	NUM
gra-1894	25	71	31	31	NUM
gra-1894	25	72	to	to	ADP
gra-1894	25	73	40	40	NUM
gra-1894	25	74	28	28	NUM
gra-1894	25	75	20.0	20.0	NUM
gra-1894	25	76	41	41	NUM
gra-1894	25	77	to	to	ADP
gra-1894	25	78	50	50	NUM
gra-1894	25	79	52	52	NUM
gra-1894	25	80	37.1	37.1	NUM
gra-1894	25	81	51	51	NUM
gra-1894	25	82	to	to	PART
gra-1894	25	83	60	60	NUM
gra-1894	25	84	28	28	NUM
gra-1894	25	85	20.0	20.0	NUM
gra-1894	25	86	61	61	NUM
gra-1894	25	87	to	to	PART
gra-1894	25	88	70	70	NUM
gra-1894	25	89	8	8	NUM
gra-1894	25	90	5.7	5.7	NUM
gra-1894	25	91	above	above	ADP
gra-1894	25	92	70	70	NUM
gra-1894	25	93	4	4	NUM
gra-1894	25	94	2.9	2.9	NUM
gra-1894	25	95	total	total	NOUN
gra-1894	25	96	140	140	NUM
gra-1894	25	97	100.0	100.0	NUM
gra-1894	25	98	findings	finding	NOUN
gra-1894	25	99	no	no	INTJ
gra-1894	25	100	.	.	PUNCT
gra-1894	26	1	of	of	ADP
gra-1894	26	2	patients	patient	NOUN
gra-1894	26	3	percentage	percentage	VERB
gra-1894	26	4	lvh	lvh	PROPN
gra-1894	26	5	64	64	NUM
gra-1894	26	6	45.7	45.7	NUM
gra-1894	26	7	normal	normal	ADJ
gra-1894	26	8	60	60	NUM
gra-1894	26	9	42.9	42.9	NUM
gra-1894	26	10	minimal	minimal	ADJ
gra-1894	26	11	pe	pe	PROPN
gra-1894	26	12	,	,	PUNCT
gra-1894	26	13	lvh	lvh	PROPN
gra-1894	26	14	8	8	NUM
gra-1894	26	15	5.7	5.7	NUM
gra-1894	26	16	lvh	lvh	PROPN
gra-1894	26	17	,	,	PUNCT
gra-1894	26	18	ef	ef	PROPN
gra-1894	26	19	35	35	NUM
gra-1894	26	20	%	%	NOUN
gra-1894	26	21	4	4	NUM
gra-1894	26	22	2.9	2.9	NUM
gra-1894	26	23	severe	severe	ADJ
gra-1894	26	24	mr	mr	PROPN
gra-1894	26	25	ef	ef	PROPN
gra-1894	26	26	35	35	NUM
gra-1894	26	27	%	%	NOUN
gra-1894	26	28	4	4	NUM
gra-1894	26	29	2.9	2.9	NUM
gra-1894	26	30	total	total	NOUN
gra-1894	26	31	140	140	NUM
gra-1894	26	32	100.0	100.0	NUM
gra-1894	26	33	30	30	NUM
gra-1894	26	34	x	x	NOUN
gra-1894	26	35	gjra	gjra	PROPN
gra-1894	26	36	global	global	ADJ
gra-1894	26	37	journal	journal	PROPN
gra-1894	26	38	for	for	ADP
gra-1894	26	39	research	research	NOUN
gra-1894	26	40	analysis	analysis	NOUN
gra-1894	26	41	discussion	discussion	NOUN
gra-1894	26	42	in	in	ADP
gra-1894	26	43	our	our	PRON
gra-1894	26	44	study	study	NOUN
gra-1894	26	45	of	of	ADP
gra-1894	26	46	esrd	esrd	PROPN
gra-1894	26	47	patients	patient	NOUN
gra-1894	26	48	out	out	ADP
gra-1894	26	49	of	of	ADP
gra-1894	26	50	140	140	NUM
gra-1894	26	51	patients	patient	NOUN
gra-1894	26	52	68	68	NUM
gra-1894	26	53	(	(	PUNCT
gra-1894	26	54	48.6	48.6	NUM
gra-1894	26	55	%	%	NOUN
gra-1894	26	56	)	)	PUNCT
gra-1894	26	57	were	be	AUX
gra-1894	26	58	male	male	ADJ
gra-1894	26	59	and	and	CCONJ
gra-1894	26	60	72	72	NUM
gra-1894	26	61	(	(	PUNCT
gra-1894	26	62	51.4	51.4	NUM
gra-1894	26	63	%	%	NOUN
gra-1894	26	64	)	)	PUNCT
gra-1894	26	65	were	be	AUX
gra-1894	26	66	female	female	ADJ
gra-1894	26	67	in	in	ADP
gra-1894	26	68	a	a	DET
gra-1894	26	69	similar	similar	ADJ
gra-1894	26	70	study	study	NOUN
gra-1894	26	71	by	by	ADP
gra-1894	26	72	rajapurkar	rajapurkar	PROPN
gra-1894	26	73	et	et	PROPN
gra-1894	26	74	al	al	PROPN
gra-1894	26	75	.	.	PROPN
gra-1894	26	76	2012	2012	NUM
gra-1894	26	77	on	on	ADP
gra-1894	26	78	rst	rst	PROPN
gra-1894	26	79	report	report	NOUN
gra-1894	26	80	of	of	ADP
gra-1894	26	81	indian	indian	PROPN
gra-1894	26	82	ckd	ckd	PROPN
gra-1894	26	83	registry	registry	PROPN
gra-1894	26	84	,	,	PUNCT
gra-1894	26	85	the	the	DET
gra-1894	26	86	mean	mean	ADJ
gra-1894	26	87	age	age	NOUN
gra-1894	26	88	was	be	AUX
gra-1894	26	89	50.1	50.1	NUM
gra-1894	26	90	±	±	NUM
gra-1894	26	91	14.6	14.6	NUM
gra-1894	26	92	years	year	NOUN
gra-1894	26	93	,	,	PUNCT
gra-1894	26	94	with	with	ADP
gra-1894	26	95	m	m	PROPN
gra-1894	26	96	:	:	PUNCT
gra-1894	26	97	f	f	PROPN
gra-1894	26	98	ratio	ratio	NOUN
gra-1894	26	99	of	of	ADP
gra-1894	26	100	70:30	70:30	NUM
gra-1894	26	101	.	.	PUNCT
gra-1894	27	1	patients	patient	NOUN
gra-1894	27	2	from	from	ADP
gra-1894	27	3	north	north	NOUN
gra-1894	27	4	zone	zone	NOUN
gra-1894	27	5	were	be	AUX
gra-1894	27	6	younger	young	ADJ
gra-1894	27	7	and	and	CCONJ
gra-1894	27	8	those	those	PRON
gra-1894	27	9	from	from	ADP
gra-1894	27	10	the	the	DET
gra-1894	27	11	(	(	PUNCT
gra-1894	27	12	4)east	4)east	NUM
gra-1894	27	13	zone	zone	NOUN
gra-1894	27	14	older	old	ADJ
gra-1894	27	15	.	.	PUNCT
gra-1894	28	1	comparing	compare	VERB
gra-1894	28	2	to	to	ADP
gra-1894	28	3	this	this	DET
gra-1894	28	4	study	study	NOUN
gra-1894	28	5	in	in	ADP
gra-1894	28	6	our	our	PRON
gra-1894	28	7	study	study	NOUN
gra-1894	28	8	percentage	percentage	NOUN
gra-1894	28	9	of	of	ADP
gra-1894	28	10	female	female	ADJ
gra-1894	28	11	patients	patient	NOUN
gra-1894	28	12	more	more	ADJ
gra-1894	28	13	than	than	ADP
gra-1894	28	14	that	that	PRON
gra-1894	28	15	of	of	ADP
gra-1894	28	16	male	male	NOUN
gra-1894	28	17	.	.	PUNCT
gra-1894	29	1	in	in	ADP
gra-1894	29	2	our	our	PRON
gra-1894	29	3	study	study	NOUN
gra-1894	29	4	maximum	maximum	ADJ
gra-1894	29	5	patient	patient	NOUN
gra-1894	29	6	were	be	AUX
gra-1894	29	7	between	between	ADP
gra-1894	29	8	41	41	NUM
gra-1894	29	9	to	to	PART
gra-1894	29	10	50	50	NUM
gra-1894	29	11	years	year	NOUN
gra-1894	29	12	of	of	ADP
gra-1894	29	13	age	age	NOUN
gra-1894	29	14	52	52	NUM
gra-1894	29	15	(	(	PUNCT
gra-1894	29	16	37	37	NUM
gra-1894	29	17	%	%	NOUN
gra-1894	29	18	)	)	PUNCT
gra-1894	29	19	out	out	ADP
gra-1894	29	20	of	of	ADP
gra-1894	29	21	140	140	NUM
gra-1894	29	22	.	.	PUNCT
gra-1894	30	1	study	study	NOUN
gra-1894	30	2	by	by	ADP
gra-1894	30	3	p.p	p.p	PROPN
gra-1894	30	4	.	.	PROPN
gra-1894	30	5	verma	verma	PROPN
gra-1894	30	6	et	et	PROPN
gra-1894	30	7	al	al	PROPN
gra-1894	30	8	2015	2015	NUM
gra-1894	30	9	published	publish	VERB
gra-1894	30	10	from	from	ADP
gra-1894	30	11	a	a	DET
gra-1894	30	12	rural	rural	ADJ
gra-1894	30	13	belt	belt	NOUN
gra-1894	30	14	of	of	ADP
gra-1894	30	15	karnataka	karnataka	PROPN
gra-1894	30	16	.	.	PUNCT
gra-1894	31	1	the	the	DET
gra-1894	31	2	population	population	NOUN
gra-1894	31	3	had	have	VERB
gra-1894	31	4	a	a	DET
gra-1894	31	5	mean	mean	ADJ
gra-1894	31	6	age	age	NOUN
gra-1894	31	7	of	of	ADP
gra-1894	31	8	39.88	39.88	NUM
gra-1894	31	9	±	±	NUM
gra-1894	31	10	15.87	15.87	NUM
gra-1894	31	11	years	year	NOUN
gra-1894	31	12	.	.	PUNCT
gra-1894	32	1	study	study	NOUN
gra-1894	32	2	by	by	ADP
gra-1894	32	3	agraval	agraval	NOUN
gra-1894	32	4	et	et	PROPN
gra-1894	32	5	al	al	PROPN
gra-1894	32	6	mean	mean	VERB
gra-1894	32	7	age	age	NOUN
gra-1894	32	8	was	be	AUX
gra-1894	32	9	42+/-13	42+/-13	NUM
gra-1894	32	10	,	,	PUNCT
gra-1894	32	11	singhal	singhal	PROPN
gra-1894	32	12	et	et	PROPN
gra-1894	32	13	al	al	PROPN
gra-1894	32	14	.	.	PROPN
gra-1894	32	15	was	be	AUX
gra-1894	32	16	45	45	NUM
gra-1894	32	17	+	+	NOUN
gra-1894	32	18	/-15	/-15	ADJ
gra-1894	32	19	.the	.the	PRON
gra-1894	32	20	age	age	NOUN
gra-1894	32	21	group	group	NOUN
gra-1894	32	22	of	of	ADP
gra-1894	32	23	our	our	PRON
gra-1894	32	24	study	study	NOUN
gra-1894	32	25	was	be	AUX
gra-1894	32	26	more	more	ADV
gra-1894	32	27	or	or	CCONJ
gra-1894	32	28	less	less	ADV
gra-1894	32	29	similar	similar	ADJ
gra-1894	32	30	to	to	ADP
gra-1894	32	31	that	that	PRON
gra-1894	32	32	of	of	ADP
gra-1894	32	33	agraval	agraval	NOUN
gra-1894	32	34	et	et	NOUN
gra-1894	32	35	(	(	PUNCT
gra-1894	32	36	5)al	5)al	PROPN
gra-1894	32	37	study	study	NOUN
gra-1894	32	38	.	.	PUNCT
gra-1894	33	1	in	in	ADP
gra-1894	33	2	our	our	PRON
gra-1894	33	3	study	study	NOUN
gra-1894	33	4	out	out	ADP
gra-1894	33	5	of	of	ADP
gra-1894	33	6	140	140	NUM
gra-1894	33	7	patients	patient	NOUN
gra-1894	33	8	lvh	lvh	PROPN
gra-1894	33	9	was	be	AUX
gra-1894	33	10	present	present	ADJ
gra-1894	33	11	64(45.7	64(45.7	NOUN
gra-1894	33	12	%	%	NOUN
gra-1894	33	13	)	)	PUNCT
gra-1894	33	14	patients	patient	NOUN
gra-1894	33	15	,	,	PUNCT
gra-1894	33	16	2decho	2decho	NUM
gra-1894	33	17	was	be	AUX
gra-1894	33	18	normal	normal	ADJ
gra-1894	33	19	in	in	ADP
gra-1894	33	20	60(42.9%),reduced	60(42.9%),reduced	ADJ
gra-1894	33	21	ejection	ejection	NOUN
gra-1894	33	22	fraction	fraction	NOUN
gra-1894	33	23	in	in	ADP
gra-1894	33	24	4(2.9	4(2.9	NUM
gra-1894	33	25	%	%	NOUN
gra-1894	33	26	)	)	PUNCT
gra-1894	33	27	,	,	PUNCT
gra-1894	33	28	valvular	valvular	ADJ
gra-1894	33	29	heart	heart	NOUN
gra-1894	33	30	disease	disease	NOUN
gra-1894	33	31	in	in	ADP
gra-1894	33	32	4(2.9	4(2.9	NUM
gra-1894	33	33	%	%	NOUN
gra-1894	33	34	)	)	PUNCT
gra-1894	33	35	.	.	PUNCT
gra-1894	34	1	dhamija	dhamija	PROPN
gra-1894	34	2	jp	jp	PROPN
gra-1894	34	3	,	,	PUNCT
gra-1894	34	4	saxena	saxena	PROPN
gra-1894	34	5	n	n	CCONJ
gra-1894	34	6	,	,	PUNCT
gra-1894	34	7	et	et	PROPN
gra-1894	34	8	al	al	PROPN
gra-1894	34	9	in	in	ADP
gra-1894	34	10	their	their	PRON
gra-1894	34	11	study	study	NOUN
gra-1894	34	12	out	out	ADP
gra-1894	34	13	of	of	ADP
gra-1894	34	14	35	35	NUM
gra-1894	34	15	esrd	esrd	PROPN
gra-1894	34	16	patients	patient	NOUN
gra-1894	34	17	,	,	PUNCT
gra-1894	34	18	echocardiography	echocardiography	NOUN
gra-1894	34	19	revealed	reveal	VERB
gra-1894	34	20	lv	lv	PROPN
gra-1894	34	21	dilatation	dilatation	NOUN
gra-1894	34	22	and	and	CCONJ
gra-1894	34	23	dias	dia	NOUN
gra-1894	34	24	tolic	tolic	NOUN
gra-1894	34	25	dysfunction	dysfunction	NOUN
gra-1894	34	26	in	in	ADP
gra-1894	34	27	18	18	NUM
gra-1894	34	28	patients	patient	NOUN
gra-1894	34	29	(	(	PUNCT
gra-1894	34	30	51.2	51.2	NUM
gra-1894	34	31	%	%	NOUN
gra-1894	34	32	)	)	PUNCT
gra-1894	34	33	,	,	PUNCT
gra-1894	34	34	lv	lv	PROPN
gra-1894	34	35	hypertrophy	hypertrophy	NOUN
gra-1894	34	36	in	in	ADP
gra-1894	34	37	17	17	NUM
gra-1894	34	38	patients	patient	NOUN
gra-1894	34	39	(	(	PUNCT
gra-1894	34	40	48	48	NUM
gra-1894	34	41	%	%	NOUN
gra-1894	34	42	)	)	PUNCT
gra-1894	34	43	,	,	PUNCT
gra-1894	34	44	systolic	systolic	ADJ
gra-1894	34	45	dysfunction	dysfunction	NOUN
gra-1894	34	46	and	and	CCONJ
gra-1894	34	47	pericardial	pericardial	ADJ
gra-1894	34	48	effusion	effusion	NOUN
gra-1894	34	49	in	in	ADP
gra-1894	34	50	(	(	PUNCT
gra-1894	34	51	6	6	NUM
gra-1894	34	52	)	)	SYM
gra-1894	34	53	10	10	NUM
gra-1894	34	54	patients	patient	NOUN
gra-1894	34	55	(	(	PUNCT
gra-1894	34	56	28.57	28.57	NUM
gra-1894	34	57	%	%	NOUN
gra-1894	34	58	)	)	PUNCT
gra-1894	34	59	and	and	CCONJ
gra-1894	34	60	6	6	NUM
gra-1894	34	61	patients	patient	NOUN
gra-1894	34	62	(	(	PUNCT
gra-1894	34	63	17.14	17.14	NUM
gra-1894	34	64	%	%	NOUN
gra-1894	34	65	)	)	PUNCT
gra-1894	34	66	respectively	respectively	ADV
gra-1894	34	67	.	.	PUNCT
gra-1894	35	1	the	the	DET
gra-1894	35	2	percentage	percentage	NOUN
gra-1894	35	3	of	of	ADP
gra-1894	35	4	lvh	lvh	PROPN
gra-1894	35	5	more	more	ADV
gra-1894	35	6	or	or	CCONJ
gra-1894	35	7	less	less	ADV
gra-1894	35	8	similar	similar	ADJ
gra-1894	35	9	to	to	ADP
gra-1894	35	10	our	our	PRON
gra-1894	35	11	study	study	NOUN
gra-1894	35	12	.in	.in	PUNCT
gra-1894	35	13	their	their	PRON
gra-1894	35	14	study	study	NOUN
gra-1894	35	15	hypertensive	hypertensive	ADJ
gra-1894	35	16	patients	patient	NOUN
gra-1894	35	17	were	be	AUX
gra-1894	35	18	27	27	NUM
gra-1894	35	19	of	of	ADP
gra-1894	35	20	35	35	NUM
gra-1894	35	21	esrd	esrd	PROPN
gra-1894	35	22	patients	patient	NOUN
gra-1894	35	23	,	,	PUNCT
gra-1894	35	24	13	13	NUM
gra-1894	35	25	out	out	ADP
gra-1894	35	26	of	of	ADP
gra-1894	35	27	27	27	NUM
gra-1894	35	28	had	have	VERB
gra-1894	35	29	higher	high	ADJ
gra-1894	35	30	prevalence	prevalence	NOUN
gra-1894	35	31	of	of	ADP
gra-1894	35	32	lvh	lvh	PROPN
gra-1894	35	33	(	(	PUNCT
gra-1894	35	34	51.85	51.85	NUM
gra-1894	35	35	%	%	NOUN
gra-1894	35	36	)	)	PUNCT
gra-1894	35	37	.	.	PUNCT
gra-1894	36	1	systolic	systolic	ADJ
gra-1894	36	2	dysfunction	dysfunction	NOUN
gra-1894	36	3	and	and	CCONJ
gra-1894	36	4	rwma	rwma	NOUN
gra-1894	36	5	was	be	AUX
gra-1894	36	6	absent	absent	ADJ
gra-1894	36	7	in	in	ADP
gra-1894	36	8	normotensive	normotensive	ADJ
gra-1894	36	9	group	group	NOUN
gra-1894	36	10	.	.	PUNCT
gra-1894	37	1	concluding	conclude	VERB
gra-1894	37	2	that	that	SCONJ
gra-1894	37	3	lv	lv	PROPN
gra-1894	37	4	diastolic	diastolic	ADJ
gra-1894	37	5	dysfunction	dysfunction	NOUN
gra-1894	37	6	and	and	CCONJ
gra-1894	37	7	hypertrophy	hypertrophy	NOUN
gra-1894	37	8	(	(	PUNCT
gra-1894	37	9	6)were	6)were	NUM
gra-1894	37	10	most	most	ADV
gra-1894	37	11	common	common	ADJ
gra-1894	37	12	echocardiographic	echocardiographic	ADJ
gra-1894	37	13	ndings	nding	NOUN
gra-1894	37	14	.	.	PUNCT
gra-1894	38	1	conclusion	conclusion	PROPN
gra-1894	38	2	esrd	esrd	PROPN
gra-1894	38	3	causes	cause	VERB
gra-1894	38	4	structural	structural	ADJ
gra-1894	38	5	and	and	CCONJ
gra-1894	38	6	functional	functional	ADJ
gra-1894	38	7	abnormality	abnormality	NOUN
gra-1894	38	8	contri	contri	NOUN
gra-1894	38	9	buting	bute	VERB
gra-1894	38	10	to	to	ADP
gra-1894	38	11	major	major	ADJ
gra-1894	38	12	cardiovascular	cardiovascular	ADJ
gra-1894	38	13	events.most	events.most	ADP
gra-1894	38	14	common	common	ADJ
gra-1894	38	15	nding	nding	NOUN
gra-1894	38	16	was	be	AUX
gra-1894	38	17	lvh	lvh	PROPN
gra-1894	38	18	.	.	PUNCT
gra-1894	39	1	hypertension	hypertension	NOUN
gra-1894	39	2	and	and	CCONJ
gra-1894	39	3	anemia	anemia	NOUN
gra-1894	39	4	are	be	AUX
gra-1894	39	5	the	the	DET
gra-1894	39	6	other	other	ADJ
gra-1894	39	7	risk	risk	NOUN
gra-1894	39	8	factor	factor	NOUN
gra-1894	39	9	to	to	PART
gra-1894	39	10	aggravate	aggravate	VERB
gra-1894	39	11	this	this	DET
gra-1894	39	12	condition	condition	NOUN
gra-1894	39	13	.hence	.hence	ADP
gra-1894	39	14	lvh	lvh	PROPN
gra-1894	39	15	is	be	AUX
gra-1894	39	16	having	have	VERB
gra-1894	39	17	prognostic	prognostic	ADJ
gra-1894	39	18	importance	importance	NOUN
gra-1894	39	19	detects	detect	NOUN
gra-1894	39	20	early	early	ADJ
gra-1894	39	21	changes	change	NOUN
gra-1894	39	22	in	in	ADP
gra-1894	39	23	cardiac	cardiac	ADJ
gra-1894	39	24	parameters	parameter	NOUN
gra-1894	39	25	.	.	PUNCT
gra-1894	40	1	screening	screen	VERB
gra-1894	40	2	of	of	ADP
gra-1894	40	3	patients	patient	NOUN
gra-1894	40	4	with	with	ADP
gra-1894	40	5	esrd	esrd	PROPN
gra-1894	40	6	adds	add	VERB
gra-1894	40	7	a	a	DET
gra-1894	40	8	therapeutic	therapeutic	NOUN
gra-1894	40	9	as	as	ADV
gra-1894	40	10	well	well	ADV
gra-1894	40	11	as	as	ADP
gra-1894	40	12	prognostic	prognostic	ADJ
gra-1894	40	13	importance	importance	NOUN
gra-1894	40	14	.	.	PUNCT
gra-1894	41	1	references	reference	NOUN
gra-1894	41	2	:	:	PUNCT
gra-1894	42	1	1	1	X
gra-1894	42	2	.	.	X
gra-1894	42	3	k	k	X
gra-1894	42	4	/	/	SYM
gra-1894	42	5	doqi	doqi	PROPN
gra-1894	42	6	clinical	clinical	ADJ
gra-1894	42	7	practice	practice	NOUN
gra-1894	42	8	guidelines	guideline	NOUN
gra-1894	42	9	for	for	ADP
gra-1894	42	10	chronic	chronic	ADJ
gra-1894	42	11	kidney	kidney	NOUN
gra-1894	42	12	disease	disease	NOUN
gra-1894	42	13	:	:	PUNCT
gra-1894	42	14	evaluation	evaluation	NOUN
gra-1894	42	15	,	,	PUNCT
gra-1894	42	16	classication	classication	NOUN
gra-1894	42	17	,	,	PUNCT
gra-1894	42	18	and	and	CCONJ
gra-1894	42	19	stratication.national	stratication.national	PROPN
gra-1894	42	20	kidney	kidney	NOUN
gra-1894	42	21	foundation.am	foundation.am	ADP
gra-1894	42	22	j	j	PROPN
gra-1894	42	23	kidney	kidney	PROPN
gra-1894	42	24	dis	dis	PROPN
gra-1894	42	25	.	.	PUNCT
gra-1894	43	1	2002	2002	NUM
gra-1894	43	2	feb	feb	NOUN
gra-1894	43	3	;	;	PUNCT
gra-1894	43	4	39(2	39(2	NUM
gra-1894	43	5	suppl	suppl	ADJ
gra-1894	43	6	1):s1	1):s1	NUM
gra-1894	43	7	-	-	SYM
gra-1894	43	8	266	266	NUM
gra-1894	43	9	.	.	PUNCT
gra-1894	43	10	)	)	PUNCT
gra-1894	44	1	2	2	X
gra-1894	44	2	.	.	PUNCT
gra-1894	44	3	denition	denition	NOUN
gra-1894	44	4	and	and	CCONJ
gra-1894	44	5	classication	classication	NOUN
gra-1894	44	6	of	of	ADP
gra-1894	44	7	ckd	ckd	PROPN
gra-1894	44	8	.	.	PUNCT
gra-1894	45	1	kidney	kidney	PROPN
gra-1894	45	2	int	int	PROPN
gra-1894	45	3	suppl	suppl	PROPN
gra-1894	45	4	(	(	PUNCT
gra-1894	45	5	2011	2011	NUM
gra-1894	45	6	)	)	PUNCT
gra-1894	45	7	.	.	PUNCT
gra-1894	46	1	2013;3(1):19–62	2013;3(1):19–62	NUM
gra-1894	46	2	.	.	PUNCT
gra-1894	46	3	doi:10.1038	doi:10.1038	NOUN
gra-1894	46	4	/	/	SYM
gra-1894	46	5	kisup.2012.64	kisup.2012.64	NOUN
gra-1894	46	6	3	3	NUM
gra-1894	46	7	.	.	PUNCT
gra-1894	47	1	prim	prim	ADJ
gra-1894	47	2	care	care	NOUN
gra-1894	47	3	.	.	PUNCT
gra-1894	48	1	2008	2008	NUM
gra-1894	48	2	jun	jun	PROPN
gra-1894	48	3	;	;	PUNCT
gra-1894	48	4	35(2	35(2	NUM
gra-1894	48	5	):	):	PUNCT
gra-1894	48	6	329–vii.robert	329–vii.robert	NUM
gra-1894	48	7	thomasabbas	thomasabbas	PROPN
gra-1894	48	8	kansojohn	kansojohn	PROPN
gra-1894	48	9	r.	r.	PROPN
gra-1894	48	10	sedor“chronic	sedor“chronic	PROPN
gra-1894	48	11	kidney	kidney	PROPN
gra-1894	48	12	disease	disease	NOUN
gra-1894	48	13	and	and	CCONJ
gra-1894	48	14	its	its	PRON
gra-1894	48	15	complications	complication	NOUN
gra-1894	48	16	.	.	PUNCT
gra-1894	48	17	”	"	PUNCT
gra-1894	48	18	primary	primary	ADJ
gra-1894	48	19	care	care	NOUN
gra-1894	48	20	vol	vol	NOUN
gra-1894	48	21	.	.	PUNCT
gra-1894	49	1	35,2	35,2	NUM
gra-1894	49	2	(	(	PUNCT
gra-1894	49	3	2008	2008	NUM
gra-1894	49	4	):	):	PUNCT
gra-1894	49	5	329	329	NUM
gra-1894	49	6	-	-	SYM
gra-1894	49	7	44	44	NUM
gra-1894	49	8	,	,	PUNCT
gra-1894	49	9	vii	vii	PROPN
gra-1894	49	10	.	.	PROPN
gra-1894	49	11	4	4	NUM
gra-1894	49	12	.	.	X
gra-1894	50	1	rajapurkar	rajapurkar	PROPN
gra-1894	50	2	,	,	PUNCT
gra-1894	50	3	m.m	m.m	PROPN
gra-1894	50	4	.	.	PROPN
gra-1894	50	5	,	,	PUNCT
gra-1894	50	6	john	john	PROPN
gra-1894	50	7	,	,	PUNCT
gra-1894	50	8	g.t	g.t	PROPN
gra-1894	50	9	.	.	PROPN
gra-1894	50	10	,	,	PUNCT
gra-1894	50	11	kirpalani	kirpalani	PROPN
gra-1894	50	12	,	,	PUNCT
gra-1894	50	13	a.l	a.l	PROPN
gra-1894	50	14	.	.	PROPN
gra-1894	50	15	et	et	PROPN
gra-1894	50	16	al	al	PROPN
gra-1894	50	17	.	.	PUNCT
gra-1894	51	1	what	what	PRON
gra-1894	51	2	do	do	AUX
gra-1894	51	3	we	we	PRON
gra-1894	51	4	know	know	VERB
gra-1894	51	5	about	about	ADP
gra-1894	51	6	chronic	chronic	ADJ
gra-1894	51	7	kidney	kidney	NOUN
gra-1894	51	8	disease	disease	NOUN
gra-1894	51	9	in	in	ADP
gra-1894	51	10	india	india	PROPN
gra-1894	51	11	:	:	PUNCT
gra-1894	52	1	rst	rst	VERB
gra-1894	52	2	report	report	NOUN
gra-1894	52	3	of	of	ADP
gra-1894	52	4	the	the	DET
gra-1894	52	5	indian	indian	PROPN
gra-1894	52	6	ckd	ckd	PROPN
gra-1894	52	7	registry	registry	PROPN
gra-1894	52	8	.	.	PUNCT
gra-1894	53	1	bmc	bmc	PROPN
gra-1894	53	2	nephrol	nephrol	NOUN
gra-1894	53	3	13	13	NUM
gra-1894	53	4	,	,	PUNCT
gra-1894	53	5	10	10	NUM
gra-1894	53	6	(	(	PUNCT
gra-1894	53	7	2012	2012	NUM
gra-1894	53	8	)	)	PUNCT
gra-1894	53	9	doi:10.1186/1471	doi:10.1186/1471	NOUN
gra-1894	53	10	-	-	PUNCT
gra-1894	53	11	2369	2369	NUM
gra-1894	53	12	-	-	SYM
gra-1894	53	13	13	13	NUM
gra-1894	53	14	-	-	SYM
gra-1894	53	15	1	1	NUM
gra-1894	53	16	.	.	NOUN
gra-1894	53	17	5	5	NUM
gra-1894	53	18	.	.	X
gra-1894	53	19	varma	varma	PROPN
gra-1894	53	20	pp	pp	PROPN
gra-1894	53	21	.	.	PUNCT
gra-1894	54	1	prevalence	prevalence	NOUN
gra-1894	54	2	of	of	ADP
gra-1894	54	3	chronic	chronic	ADJ
gra-1894	54	4	kidney	kidney	NOUN
gra-1894	54	5	disease	disease	NOUN
gra-1894	54	6	in	in	ADP
gra-1894	54	7	india	india	PROPN
gra-1894	54	8	where	where	SCONJ
gra-1894	54	9	are	be	AUX
gra-1894	54	10	we	we	PRON
gra-1894	54	11	heading	head	VERB
gra-1894	54	12	?	?	PUNCT
gra-1894	54	13	.	.	PUNCT
gra-1894	55	1	indian	indian	PROPN
gra-1894	55	2	j	j	PROPN
gra-1894	55	3	nephrol	nephrol	PROPN
gra-1894	55	4	.	.	PUNCT
gra-1894	56	1	2015;25(3):133–135	2015;25(3):133–135	NUM
gra-1894	56	2	.	.	NOUN
gra-1894	56	3	6	6	NUM
gra-1894	56	4	.	.	X
gra-1894	56	5	dhamija	dhamija	PROPN
gra-1894	56	6	jp	jp	PROPN
gra-1894	56	7	,	,	PUNCT
gra-1894	56	8	saxena	saxena	PROPN
gra-1894	56	9	n	n	PROPN
gra-1894	56	10	,	,	PUNCT
gra-1894	56	11	saxena	saxena	PROPN
gra-1894	56	12	s.	s.	PROPN
gra-1894	56	13	evaluation	evaluation	NOUN
gra-1894	56	14	of	of	ADP
gra-1894	56	15	2	2	NUM
gra-1894	56	16	-	-	PUNCT
gra-1894	56	17	d	d	NOUN
gra-1894	56	18	echo	echo	NOUN
gra-1894	56	19	ndings	nding	NOUN
gra-1894	56	20	in	in	ADP
gra-1894	56	21	chronic	chronic	ADJ
gra-1894	56	22	kidney	kidney	NOUN
gra-1894	56	23	disease	disease	NOUN
gra-1894	56	24	:	:	PUNCT
gra-1894	56	25	case	case	NOUN
gra-1894	56	26	study	study	NOUN
gra-1894	56	27	of	of	ADP
gra-1894	56	28	35	35	NUM
gra-1894	56	29	end	end	NOUN
gra-1894	56	30	stage	stage	NOUN
gra-1894	56	31	renal	renal	ADJ
gra-1894	56	32	disease	disease	NOUN
gra-1894	56	33	patients	patient	NOUN
gra-1894	56	34	.	.	PUNCT
gra-1894	57	1	iaim	iaim	NOUN
gra-1894	57	2	,	,	PUNCT
gra-1894	57	3	2016	2016	NUM
gra-1894	57	4	;	;	PUNCT
gra-1894	57	5	3(9	3(9	NUM
gra-1894	57	6	):	):	PUNCT
gra-1894	57	7	61	61	NUM
gra-1894	57	8	-	-	SYM
gra-1894	57	9	65	65	NUM
gra-1894	57	10	.	.	PUNCT
gra-1894	58	1	7	7	NUM
gra-1894	58	2	.	.	PUNCT
gra-1894	58	3	muntner	muntner	NOUN
gra-1894	58	4	p	p	NOUN
gra-1894	58	5	,	,	PUNCT
gra-1894	58	6	he	he	PRON
gra-1894	58	7	j	j	PROPN
gra-1894	58	8	,	,	PUNCT
gra-1894	58	9	astor	astor	PROPN
gra-1894	58	10	bc	bc	PROPN
gra-1894	58	11	,	,	PUNCT
gra-1894	58	12	folsom	folsom	PROPN
gra-1894	58	13	ar	ar	PROPN
gra-1894	58	14	,	,	PUNCT
gra-1894	58	15	coresh	coresh	PROPN
gra-1894	58	16	j	j	PROPN
gra-1894	58	17	j	j	PROPN
gra-1894	58	18	am	be	AUX
gra-1894	58	19	soc	soc	NOUN
gra-1894	58	20	nephrol	nephrol	NOUN
gra-1894	58	21	.	.	PUNCT
gra-1894	59	1	2005	2005	NUM
gra-1894	59	2	feb	feb	NOUN
gra-1894	59	3	;	;	PUNCT
gra-1894	59	4	16(2):529	16(2):529	NUM
gra-1894	59	5	-	-	SYM
gra-1894	59	6	38	38	NUM
gra-1894	59	7	.	.	NOUN
gra-1894	59	8	8	8	NUM
gra-1894	59	9	.	.	PUNCT
gra-1894	60	1	levin	levin	PROPN
gra-1894	60	2	a	a	PROPN
gra-1894	60	3	,	,	PUNCT
gra-1894	60	4	singer	singer	NOUN
gra-1894	60	5	j	j	PROPN
gra-1894	60	6	,	,	PUNCT
gra-1894	60	7	thompson	thompson	PROPN
gra-1894	60	8	cr	cr	PROPN
gra-1894	60	9	,	,	PUNCT
gra-1894	60	10	ross	ross	PROPN
gra-1894	60	11	h	h	PROPN
gra-1894	60	12	,	,	PUNCT
gra-1894	60	13	lewis	lewis	PROPN
gra-1894	60	14	m	m	PROPN
gra-1894	60	15	am	be	AUX
gra-1894	60	16	j	j	PROPN
gra-1894	60	17	kidney	kidney	PROPN
gra-1894	60	18	dis	dis	PROPN
gra-1894	60	19	.	.	PUNCT
gra-1894	61	1	1996	1996	NUM
gra-1894	61	2	mar	mar	PROPN
gra-1894	61	3	;	;	PUNCT
gra-1894	61	4	27(3):347	27(3):347	PROPN
gra-1894	61	5	-	-	SYM
gra-1894	61	6	54	54	NUM
gra-1894	61	7	.	.	NOUN
gra-1894	61	8	9	9	X
gra-1894	61	9	.	.	X
gra-1894	61	10	chronic	chronic	ADJ
gra-1894	61	11	kidney	kidney	NOUN
gra-1894	61	12	disease	disease	NOUN
gra-1894	61	13	in	in	ADP
gra-1894	61	14	india	india	PROPN
gra-1894	61	15	:	:	PUNCT
gra-1894	61	16	challenges	challenge	NOUN
gra-1894	61	17	and	and	CCONJ
gra-1894	61	18	solutions.agarwal	solutions.agarwal	NUM
gra-1894	61	19	sk1	sk1	PROPN
gra-1894	61	20	,	,	PUNCT
gra-1894	61	21	srivastava	srivastava	PROPN
gra-1894	61	22	rk	rk	PROPN
gra-1894	61	23	.	.	PUNCT
gra-1894	61	24	)	)	PUNCT
gra-1894	62	1	volume-9	volume-9	NUM
gra-1894	62	2	,	,	PUNCT
gra-1894	62	3	issue-2	issue-2	PROPN
gra-1894	62	4	,	,	PUNCT
gra-1894	62	5	february-2020	february-2020	VERB
gra-1894	62	6	•	•	NUM
gra-1894	62	7	print	print	NOUN
gra-1894	62	8	issn	issn	PROPN
gra-1894	62	9	no	no	NOUN
gra-1894	62	10	.	.	PROPN
gra-1894	63	1	2277	2277	NUM
gra-1894	63	2	8160	8160	NUM
gra-1894	63	3	•	•	NOUN
gra-1894	63	4	doi	doi	NOUN
gra-1894	63	5	:	:	PUNCT
gra-1894	63	6	10.36106	10.36106	NUM
gra-1894	63	7	/	/	SYM
gra-1894	63	8	gjra	gjra	NOUN
gra-1894	63	9	x	x	SYM
gra-1894	63	10	31gjra	31gjra	NUM
gra-1894	63	11	global	global	ADJ
gra-1894	63	12	journal	journal	NOUN
gra-1894	63	13	for	for	ADP
gra-1894	63	14	research	research	NOUN
gra-1894	63	15	analysis	analysis	NOUN